TiVo (NASDAQ:TIVO) said a Texas court has rejected EchoStar's (NASDAQ:SATS) attempted workaround claim regarding the TiVo patent. EchoStar was found to be in contempt of court. The court also ordered the permanent injunction fully enforced. Additionally, the court awarded TiVo 103 million dollars plus interest through April 2008. Tivo shares rocketed 46% higher Wednesday morning.
Dynavax (NASDAQ:DVAX) presented additional Phase 3 data for its HEPLISAV hepatitis B vaccine at a Chicago medical conference. Dynavax revealed that HEPLISAV provided more rapid and better protection against hepatitis B viral infection with fewer doses. The data is particularly significant with patients over 40 years old, who are less likely to respond to immunization. Dynavax shares gained 36% in early trading Wednesday.
Angiotech Pharmaceuticals (ANPI) was trading over 28% higher on Wednesday morning, after the company announced a distribution and supply agreement with Haemacure (HAE.CA). The collaboration provides Angiotech with access to critically important technology for certain surgical product candidates currently under the company's development.
Applied Signal Technology (APSG) was trading over 16% higher early Wednesday, after reporting its earnings per share increased 94% in the quarter, to 31 cents per share versus 16 cents in the same quarter last year. CEO William Van Vleet said the company's profitability benefited from improvements in operations initiated last year, and an increase in revenue resulting from the launch of the company's new Model 680 Raider product.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.